Gene · 10643
Papers3,038
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 3,038
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of TMEM178 as a Potential Prognostic Biomarker and Therapeutic Target for Breast Cancer. | Iran J Public Health | 2023 | 38106832 | PubTator, text mining | PubMed |
| CiRS-7 Enhances the Liquid-liquid Phase Separation of miRISC and Promotes DNA Damage Repair. | Nucleus | 2023 | 38105528 | PubTator, text mining | PubMed |
| The role of m6A epigenetic modifications in tumor coding and non-coding RNA processing. | Cell Commun Signal | 2023 | 38102645 | PubTator, text mining | PubMed |
| Serum exosomal circCCDC66 as a potential diagnostic and prognostic biomarker for pituitary adenomas. | Front Oncol | 2023 | 38098508 | PubTator, text mining | PubMed |
| Combining the Tyrosine Kinase Inhibitor Cabozantinib and the mTORC1/2 Inhibitor Sapanisertib Blocks ERK Pathway Activity and Suppresses Tumor Growth in Renal Cell Carcinoma. | Cancer Res | 2023 | 38098449 | PubTator, text mining | PubMed |
| A novel circular RNA, circMAML3, promotes tumor progression of prostate cancer by regulating miR-665/MAPK8IP2 axis. | Cell Death Discov | 2023 | 38097567 | PubTator, text mining | PubMed |
| Fasting regulates mitochondrial function through lncRNA PRKCQ-AS1-mediated IGF2BPs in papillary thyroid carcinoma. | Cell Death Dis | 2023 | 38092752 | PubTator, text mining | PubMed |
| Genes with epigenetic alterations in human pancreatic islets impact mitochondrial function, insulin secretion, and type 2 diabetes. | Nat Commun | 2023 | 38086799 | PubTator, text mining | PubMed |
| circRARS synergises with IGF2BP3 to regulate RNA methylation recognition to promote tumour progression in renal cell carcinoma. | Clin Transl Med | 2023 | 38073586 | PubTator, text mining | PubMed |
| Role of N6-methyladenosine methylation in glioma: recent insights and future directions. | Cell Mol Biol Lett | 2023 | 38072944 | PubTator, text mining | PubMed |
| Circular RNA CDR1as Mediated by Human Antigen R (HuR) Promotes Gastric Cancer Growth via miR-299-3p/TGIF1 Axis. | Cancers (Basel) | 2023 | 38067260 | PubTator, text mining | PubMed |
| Kinetic FRET Assay to Measure Binding-Induced Conformational Changes of Nucleic Acids. | ACS Sens | 2023 | 38060303 | PubTator, text mining | PubMed |
| IGF2BP3-mediated regulation of GLS and GLUD1 gene expression promotes treg-induced immune escape in human cervical cancer. | Am J Cancer Res | 2023 | 38058838 | PubTator, text mining | PubMed |
| m6A modification patterns are associated with copy number burden and tumor immune landscape in thyroid cancer. | BMC Endocr Disord | 2023 | 38057752 | PubTator, text mining | PubMed |
| Overexpression of TMEM150A in glioblastoma multiforme patients correlated with dismal prognoses and compromised immune statuses. | PLoS One | 2023 | 38055673 | PubTator, text mining | PubMed |
| Effects of RNA methylation on Tumor angiogenesis and cancer progression. | Mol Cancer | 2023 | 38053093 | PubTator, text mining | PubMed |
| RNA binding protein IGF2BP2 expression is induced by stress in the heart and mediates dilated cardiomyopathy. | Commun Biol | 2023 | 38052926 | PubTator, text mining | PubMed |
| TMEM44-AS1 promotes esophageal squamous cell carcinoma progression by regulating the IGF2BP2-GPX4 axis in modulating ferroptosis. | Cell Death Discov | 2023 | 38040698 | PubTator, text mining | PubMed |
| Low-density lipoprotein receptor promotes crosstalk between cell stemness and tumor immune microenvironment in breast cancer: a large data-based multi-omics study. | J Transl Med | 2023 | 38037058 | PubTator, text mining | PubMed |
| M6A RNA methylation modification and tumor immune microenvironment in lung adenocarcinoma. | Biophys Rep | 2023 | 38028153 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10643/papers?page=24